Table 2.
Exogenous iNO (%) | Milrinone (%) | Bosentan (%) | Systemic steroids (%) | Inhaled steroids (%) | |
---|---|---|---|---|---|
Mourani et al.30 | 72.0 | 16.0 | 8.0 | 0.0 | 0.0 |
Nyp et al.31 | 52.4 | 19.0 | 0.0 | 42.9 | 47.6 |
Tan et al.32 | 4.5 | NR | 0.0 | 0.0 | 0.0 |
Trottier-Boucher et al.33 | 91.3 | 0.0 | 17.4 | 0.0 | 34.8 |
Kadmon et al.29 | NR | NR | 29.4 | NR | NR |
Pooled total | 54.9 | 11.1 | 10.3 | 10.7 | 21.4 |
NR, variable not reported.